YCYuhan Cui

Yuhan Cui

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yuhan Cui has a total of 113 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Identity-Duplication Auditing in National-Scale Neuroimaging Repositories

    by Jiheng Li, Michael E. Kim, Trent M. Schwartz, Yuhan Cui, Gaurav Rudravaram, Derek B. Archer, Timothy Hohman, Lori L. Beason-Held, Victoria L. Morgan, Dario Englot, et al.

    Objective . National-scale magnetic resonance imaging (MRI) repositories increasingly integrate data from different studies and institutions. However, subject identifiers that are valid only within individual datasets are no longer guaranteed to remain globally unique after aggregation, making it possible for the same subject to be assigned multiple identifiers, which we define as identity duplication. Such duplication can create leakage between training and test data and inflate apparent performance in downstream biomedical studies. Existing methods do not provide an end-to-end, image-based workflow for auditing this problem at repository scale. Methods. HAPPEN is a human-in-the-loop pipeline for auditing identity duplication in T1-weighted brain MRI repositories. It combines SHA-256 fingerprinting for exact-duplicate detection with supervised contrastive retrieval of non-identical scans that may originate from the same person. Retrieved pairs are reviewed as candidates in a locally hosted interface rather than automatically classified as duplicates. We benchmarked retrieval against PCA and 3D-SIFT-Rank in an internal test set and two withheld cohorts. We deployed the workflow in a 95,129-scan aggregated repository and assessed end-to-end recovery using 54 genetic-reference pairs. Transferability was assessed by locally deploying the same workflow on 22,386 scans at an independent institution without model retraining or image transfer.Results. HAPPEN achieved near-ceiling same-subject retrieval across all three cohorts and matched or exceeded the baseline point estimates on every metric. Deployment in the study repository identified 1,316 exact-duplicate scan groups and 1,275 reviewer-supported near-duplicate subject groups. Of these groups, 56% and 82%, respectively, crossed dataset boundaries. All 54 genetic-reference pairs were recovered. The external team independently completed the full workflow using a locally selected operating threshold and review standard.Conclusion. Together, these findings indicate that identity duplication is a structural risk of MRI repository aggregation and that HAPPEN can support practical, locally governed quality assurance.

  • Open Access

    Plasma GDF15 affects long-term dementia risk and alters neuroimmune signaling

    by Cassandra O. Blew, Michael R. Duggan, Dimitrios Tsitsipatis, Gabriela T. Gomez, Zulema Rodriguez-Hernandez, Luke C. Pilling, Jingsha Chen, Eva Jacobsen, Heather E. Dark, Yifei Lu, et al.

    Growth/differentiation factor–15 (GDF15) is a secreted cytokine strongly associated with dementia risk. However, the extent to which GDF15 represents a biomarker and driver of dementia risk remains unclear. Across multiple cohorts, we demonstrated that plasma GDF15 is associated with greater dementia risk over 15- to 25-year follow-up periods when measured in midlife, with stronger associations observed for vascular, compared to Alzheimer’s disease (AD), dementia. Two-sample Mendelian randomization supported plasma GDF15’s mechanistic role in AD and related dementias, while cohort studies linked it to cerebral small vessel disease, neurodegeneration, phosphorylated tau, and a cerebrospinal fluid proteomic signature indicative of neuroimmune activation. Exposure of cultured myeloid cells to recombinant GDF15 altered biological pathways that we subsequently demonstrated are predictive of dementia risk, including interferon/antiviral responses. These findings support circulating GDF15’s role as an early biomarker—particularly for vascular dementia and neuroinflammation—and identify the mechanisms by which it may drive dementia risk.


  • Open Access

    Proteomic signatures of corona and herpes viral antibodies identify IGDCC4 as a mediator of neurodegeneration

    by Michael R. Duggan, Shuojia Yang, Gabriela T. Gomez, Yuhan Cui, Ana W. Capuano, Jingsha Chen, Zhijian Yang, Junhao Wen, Guray Erus, Shannon M. Drouin, et al.

    Mechanisms underlying the dynamic relationships of viral infections and neurodegeneration warrant examination. Using a community-based cohort of older adults, the current study characterized the neurocognitive (cognitive functioning, brain volumes, Alzheimer’s disease positron emission tomography, and plasma biomarkers) and plasma proteomic (7268 proteins) profiles of four common coronavirus and six herpesvirus antibody titers. Genetic inference techniques demonstrated the associations between viral antibody titers and neurocognitive outcomes may be attributed to altered expression in a subset of mechanistically relevant proteins in plasma. One of these proteins, IGDCC4 (immunoglobulin superfamily deleted in colorectal cancer subclass member 4), was related to 20-year dementia risk, cognitive functioning, and amyloid-β positivity using data from two independent cohorts, while its plasma and intrathecal abundance were causally implicated in dementia risk and clinically relevant brain atrophy. Our findings illuminate the biological basis by which host immune responses to viruses may affect neurocognitive outcomes in older adults and identify IGDCC4 as an important molecular mediator of neurodegeneration.


  • Interpretable deep clustering survival machines for Alzheimer’s disease subtype discovery

    by Bojian Hou, Zixuan Wen, Jingxuan Bao, Richard Zhang, Boning Tong, Shu Yang, Junhao Wen, Yuhan Cui, Jason H. Moore, Andrew J. Saykin, et al.


  • Open Access

    Artificial intelligence reveals brain aging patterns in 27,402 individuals without diagnosed cognitive impairment that are linked to genetics, biomedical measures, and cognitive decline

    by Ioanna Skampardoni, Ilya M. Nasrallah, Junhao Wen, Yuhan Cui, Ahmed Abdulkadir, Zhijian Yang, Guray Erus, Elizabeth Mamourian, Ashish Singh, Haochang Shou, et al.

    Background: Understanding heterogeneity of structural brain changes in aging may provide insights into susceptibility to neurodegenerative diseases. We characterize the genetics underlying brain structural heterogeneity within cognitively unimpaired (CU) individuals using data‐driven machine learning applied to a diverse dataset of 27,402 individuals from 11 neuroimaging studies from the iSTAGING consortium.Method: Structural brain morphologic patterns of CU individuals were independently examined in four decade‐long intervals spanning ages 45 to 85. Within each interval, Smile‐GAN (Yang et al., 2021) was trained on baseline anatomic and white matter hyperintensity (WMH) volumes. Smile‐GAN probability scores were used as phenotypes in genome‐wide association studies (GWAS). Specifically, we performed multiple linear regressions controlling for confounders (e.g., age) via Plink (Purcell et al., 2007). We observed longitudinal clustering stability across decades, so individuals from adjacent age groups were combined into broader age groups ([45,65), [65,85)) due to the large sample requirement of GWAS. Genomic loci, represented by the top leading single nucleotide polymorphisms (SNPs), were defined considering linkage disequilibrium. We investigated associations of SNPs with clinical traits and mapped them to genes using the GWAS Catalog (Buniello et al., 2019).Result: Three structural brain aging patterns, relative to resilient agers (A0), consistent across decades, emerged: A1, or ‘typical’ aging with low atrophy and WMHs, and two ‘advanced’ aging patterns, one showing elevated WMHs and modest atrophy (A2) and the other displaying severe, widespread atrophy and moderate WMH load (A3) (Figure 1). GWAS discovered eight and six genomic loci in [45,65) and [65,85) age groups, respectively (Table 1, Figure 2). The lead SNPs for A1 and A2 were previously associated with several cardiometabolic risk factors, WMHs, and regional brain volumes. Interestingly, rs4843552, previously associated with white matter microstructure and regional brain volumes, showed opposite effects for A1 (protection) and A2 (risk), consistent with the neuroimaging patterns. WDR41 in A3 group was previously associated with the age of Alzheimer’s disease onset (Herold et al., 2016).Conclusion: Reproducible neuroimaging patterns defined by regional atrophy and WMH burden were identified across CU individuals and demonstrated unique genetics. Further research is needed to elucidate the neuropathological pathways that mediate these relationships.

  • Open Access

    Deep Learning patterns of Aβ accumulation in Alzheimer’s Disease

    by Dhivya Srinivasan, Ilya M. Nasrallah, Zhijian Yang, Murat Bilgel, Junhao Wen, Guray Erus, Yuhan Cui, Elizabeth Mamourian, Aristeidis Sotiras, Tobey J Betthauser, et al.

    Background: Accumulation of amyloid (Aß) plaques is an early pathologic change of Alzheimer’s Disease (AD). However, the mechanisms and pathways by which amyloid spreads across the cerebrum are not fully understood. Deriving distinct dimensions of amyloid deposition and their associations with biomedical factors could be useful to understand how amyloid propagates. In this analysis, we identified two distinct subtypes of progression based on spatiotemporal variations using a recently developed data‐driven, deep learning clustering method called Surreal‐GAN1.Method: We used data from 482 A+ and 801 A‐ subjects with 18F‐florbetapir PET from the Alzheimer’s Disease Neuroimaging Initiative (ADNI; N = 832) and 11C‐PiB from the Preclinical AD consortium (PAC; N = 451). Standardized uptake value ratio (SUVR) maps (cerebellar GM reference) were transformed to reference space. We derived amyloid status using Gaussian mixture modelling of mean total cortical SUVR for each of 4 sites. We then applied non‐negative matrix factorization2 on the SUVR maps to identify data‐driven common patterns of deposition across the sample. Next, we applied Surreal‐GAN on a total of 1283 subjects to determine the amyloid spatiotemporal subtypes. Correlations with clinical and cognitive variables were evaluated.Results: Participants were 30%/22% female and had mean age 74.9 (±7.4)/ 67.9(±9.1) years for ADNI and PAC, respectively. We identified 24 components from NMF (Fig 1A) after excluding 6 as non‐target features. Surreal‐GAN showed optimal agreement indices for two patterns. While both patterns shared involvement of posterior cingulate/precuneus and inferior frontal cortex, pattern r1 shows relatively more occipital deposition and pattern r2 shows more frontal deposition (Fig 1B), as seen when comparing strongly r1 vs strongly r2 participants using voxel‐based morphometry (Fig 2). Both were associated with worse global cognitive function and worsening neurodegeneration (Table 1). r1 correlates with white matter hyperintensity volume, a measure of cerebrovascular disease, while pattern r2 is associated with the presence of APOE e4 alleles.Conclusion: Employing a data‐driven deep learning‐based approach, we derived more than one dissociable pattern of amyloid deposition, potentially differently influenced by vascular disease (r1/occipital) and genetics (r1/frontal). These findings could inform identification of subgroups of individuals who may or may not be responsive to particular clinical intervention.

  • Open Access

    Brain-wide genome-wide colocalization study for integrating genetics, transcriptomics and brain morphometry in Alzheimer's disease

    by Jingxuan Bao, Junhao Wen, Zixuan Wen, Shu Yang, Yuhan Cui, Zhijian Yang, Guray Erus, Andrew J. Saykin, Qi Long, Christos Davatzikos, et al.